Successful Large-Scale Capitated Transition
Completed the largest patient transition in HME history, establishing 35 de novo locations and becoming the exclusive HME provider for >10 million new members; capitated membership increased ~7x year-over-year to about 15 million and capitated net revenue comprised 9.2% of consolidated net revenue in Q1.
Revenue Growth and Organic Performance
First quarter net revenue of $819.8 million, up 5.4% versus prior year and ~ $22 million ahead of midpoint guidance; organic growth was 9.1% year-over-year (about 500 bps from the new capitated contract and ~400 bps from base business).
Strong Segment Results — Sleep and Respiratory
Sleep Health net revenue $358.5 million, up 13.3% year-over-year with PAP new starts at a record; Respiratory Health net revenue $178.1 million, up 7.6% year-over-year and oxygen new starts grew 12.8%.
Wellness at Home Organic Recovery After Dispositions
Reported Wellness at Home net revenue declined 10.3% to $141.0 million due to $35.8 million of disposed revenue from noncore assets; after adjusting for dispositions, Wellness at Home delivered 11% organic growth.
Technology and Digital Milestones
AI-enabled initiatives moved beyond pilot with conversational AI handling live calls (scheduling, contact center, resupply); scheduling is now ~25% touchless versus manual a year ago; patient portal MyApp surpassed 412,000 users, and order conversion times shortened materially.
Refinancing Strengthens Financial Flexibility
Completed $1.1 billion refinancing in April (Term Loan A $325M, delayed draw $325M, $450M revolver) extending maturities to April 2031, lowering weighted average cost of debt and reflecting recent S&P and Moody's upgrades.
Raised Full-Year Revenue Guidance and Maintained Profitability Targets
Raised full-year net revenue projection by $10 million to $3.45B–$3.52B and maintained full-year adjusted EBITDA guidance of $680M–$730M and free cash flow guidance of $175M–$225M.
Operational Cash Flow and Outlook for Cash Generation
Q1 cash flow from operations $93.7 million (essentially flat year-over-year); company expects CapEx normalization and improving free cash flow in back half of the year, forecasting Q3 and Q4 cash flow strength (~$100 million each).